Mitchell Shirvan
Vorstandsvorsitzender bei D.H.S Medical Ltd.
Ursprung des Netzwerks ersten Grades von Mitchell Shirvan
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
VYNE Pharmaceuticals Ltd.
 VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel.
22
| Subsidiary | Pharmaceuticals: Major | 22 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Mitchell Shirvan
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal | |
| TUCOWS INC. | Data Processing Services | Chairman | |
| GIVEN IMAGING LTD. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
Warner Chilcott Ltd.
 Warner Chilcott Ltd. Pharmaceuticals: MajorHealth Technology Warner Chilcott Ltd. develops and provides pharmaceutical products. It focuses on the women’s healthcare and dermatology segment. The company was founded in 1996 and headquartered in Hamilton, Bermuda. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel Corporate Officer/Principal | |
Warner Chilcott Co., Inc.
 Warner Chilcott Co., Inc. Pharmaceuticals: MajorHealth Technology Warner Chilcott Co., Inc. develops, manufactures and markets branded prescription pharmaceutical products. The company is located in Rockaway, NJ | Pharmaceuticals: Major | Human Resources Officer General Counsel | |
| OWC PHARMACEUTICAL RESEARCH CORP. | Miscellaneous | Chairman | |
DenX Medical Software Systems Ltd.
 DenX Medical Software Systems Ltd. Medical SpecialtiesHealth Technology DenX Ltd. is engaged in manufacturing of dental equipment. The firm develops and markets image guided technology for dental training and clinical implementation. The company was founded by Hayka Alon in 1994 and is headquartered in Jerusalem, Israel. | Medical Specialties | Chairman | |
FuturaGene Ltd.
 FuturaGene Ltd. BiotechnologyHealth Technology FuturaGene Ltd. researches and develops plant genetic for global biofuel, forestry and agricultural markets. The firm operates on research, development and commercialization of technologies that provide solutions for agriculture in a changing planet. The company is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree | |
Yissum Research Development Co. Ltd.
 Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | Investment Managers | Chairman | |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Financial Conglomerates | Director/Board Member | |
FuturaGene, Inc.
 FuturaGene, Inc. Other Metals/MineralsNon-Energy Minerals FuturaGene, Inc. operates as an agricultural biotechnology firm. It researches and delivers agronomic traits that improve and protect yield for forestry, biofuels, biopower, and agriculture. The company was founded in March 2001 and is headquartered in Lafayette, IN. | Other Metals/Minerals | Chief Executive Officer | |
| Syracuse University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Cape Town | College/University | Undergraduate Degree | |
| UNIVO PHARMACEUTICALS LTD | Biotechnology | Chairman | |
| Technion-Israel Institute of Technology | College/University | Graduate Degree | |
| The Hebrew University of Jerusalem | College/University | Doctorate Degree Doctorate Degree | |
TransPharma Medical Ltd.
 TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities. | Pharmaceuticals: Major | Director/Board Member | |
Warner Chilcott, Inc.
 Warner Chilcott, Inc. Pharmaceuticals: MajorHealth Technology Warner Chilcott, Inc. develops and manufactures drugs. It makes women's health care and urology prescription drugs, dermatology and cardiology drugs. The company is headquartered in Rockaway, NJ. | Pharmaceuticals: Major | General Counsel Sales & Marketing Corporate Officer/Principal | |
CBD Technologies, Inc.
 CBD Technologies, Inc. TextilesProcess Industries Part of FuturaGene Ltd., CBD Technologies, Inc. provides biotechnology for forest improvement and the development of biologically-based, clean processes for paper manufacturing. The company is based in Bergenfield, NJ. The company was founded by Jonathan Joels, Oded Shoseyov. CBD Technologies was acquired by FuturaGene Ltd. on December 20, 2006 for $4.28 million. | Textiles | President | |
| BIOLINERX LTD. | Pharmaceuticals: Major | Chairman | |
| PROTALIX BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
American Academy of Dermatology
 American Academy of Dermatology Miscellaneous Commercial ServicesCommercial Services American Academy of Dermatology is the largest and most influential dermatology group in the United States. The private company is based in the United States and has subsidiaries in various locations. The American company provides resources on membership, education, practice management, publications, and clinical care for dermatologists. The company also offers information for patients and the public on skin, hair, and nail conditions. Elizabeth Usher has been the CEO of the company since 2019. | Miscellaneous Commercial Services | President Corporate Officer/Principal | |
| MEDIWOUND LTD. | Pharmaceuticals: Major | Director/Board Member | |
CureTech Ltd.
 CureTech Ltd. BiotechnologyHealth Technology CureTech Ltd. operates as a biotechnology company. It develops novel and immune modulating products for the treatment and control of cancer. The company was founded by Michael Schickler in 1995 and is headquartered in Yavne, Israel. | Biotechnology | Chairman | |
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Biotechnology | Chairman | |
Leo Pharma, Inc.
 Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Drugstore Chains | Sales & Marketing Corporate Officer/Principal | |
BioMAS Ltd.
 BioMAS Ltd. Pharmaceuticals: MajorHealth Technology BioMAS Ltd. is an Israeli pharmaceutical company that was founded in 2000. The private company is based in Jerusalem, Israel and develops drugs that are based on tellurium. | Pharmaceuticals: Major | Chairman | |
| Amorphical Ltd. | Chairman | ||
| Protalix Ltd. | Director/Board Member | ||
Integra Holdings Ltd.
 Integra Holdings Ltd. MiscellaneousMiscellaneous Integra Holdings Ltd. operates as a holding company. It invests in the pharmaceutical industry. The company was founded in 2012 and is headquartered in Jerusalem, Israel. | Miscellaneous | Director/Board Member | |
FlexiProbe Ltd.
 FlexiProbe Ltd. Medical SpecialtiesHealth Technology FlexiProbe Ltd. manufactures medical devices. The private company is based in Ramat-Gan, Israel. The Israeli company was founded in 2001 by Meir Eini, Dov Tamarkin. | Medical Specialties | Founder Chief Executive Officer | |
VYNE Pharmaceuticals, Inc.
 VYNE Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals, Inc. manufactures pharmaceutical products. The company was founded on May 6th, 2014 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
| Medingalil Ltd. | Director/Board Member | ||
Anthill Ventures
 Anthill Ventures Investment ManagersFinance Anthill Scale Ventures is a venture capital firm. The firm was founded in 2016 by Prasad Vanga. The firm headquartered in Hyderabad, India with additional office in Singapore, US and Israel. | Investment Managers | Private Equity Investor | |
Barcode Diagnostics Ltd.
 Barcode Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology Barcode Diagnostics Ltd. is engaged in developing a product that assesses the efficacy of different cancer drugs directly on the tumor within the body to select the optimal personalized treatment for each patient. The company was founded by Ronen Eavri, Annie Sabbah, and Avi Schroeder in February 2017 and is headquartered in Nazareth, Israel. | Pharmaceuticals: Major | Director/Board Member | |
D Pharm Ltd.
 D Pharm Ltd. BiotechnologyHealth Technology D Pharm Ltd. provides drug development services. | Biotechnology | Chairman | |
| SCOPUS BIOPHARMA INC. | Pharmaceuticals: Other | Director/Board Member | |
| VYNE THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer General Counsel Corporate Officer/Principal Human Resources Officer General Counsel Director/Board Member |
Statistik
International
| Israel | 26 |
| Vereinigte Staaten | 18 |
| Vereinigtes Königreich | 4 |
| Kanada | 2 |
| Bermuda | 2 |
Sektoral
| Health Technology | 30 |
| Consumer Services | 6 |
| Finance | 5 |
| Miscellaneous | 3 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 87 |
| Corporate Officer/Principal | 46 |
| Independent Dir/Board Member | 24 |
| Chairman | 21 |
| Undergraduate Degree | 18 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Aharon Schwartz | 29 |
| Rex Bright | 24 |
| Stanley Stern | 23 |
| Dalia Megiddo | 18 |
| Darrell S. Rigel | 13 |
| Sharon Barbari | 12 |
| Anthony Bruno | 11 |
| Stanley Hirsch | 11 |
| Anna Kazanchyan | 9 |
| David Domzalski | 8 |
| David Schuz | 8 |
| Mutya Harsch | 8 |
| Deepa Desai | 8 |
| Alvin D. Howard | 7 |
| Iain Stuart | 7 |
- Börse
- Insiders
- Mitchell Shirvan
- Unternehmensverbindungen
